According to the guidelines of the FSA ("Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V."), as a congress agency we are obliged to inform potential participants of congresses in advance of the event about the scope and conditions of support from the pharmaceutical industry. We are happy to comply with this obligation and inform you about the level of sponsorship of the participating companies as well as those companies that wish to be published voluntarily.
10x Genomics, Inc. (2,540.00 EUR); Akyoa Biosciences Inc. (5,000.00 EUR); MSD Sharp & Dohme GmbH (11,000.00 EUR)